Immunoassay in R&D Market Value to Surpass USD 7,716.6 Million Revenue Mark by 2023 at 8.18 % CAGR, Says Market Research Future

by NASDAQ Market News July 30, 2019

NASDAQ Market News
Click here to email author

Aptose Biosciences to Present at Canaccord Genuity 39th Annual Growth Conference

RECORDATI ANNOUNCES GROWTH IN THE FIRST HALF 2019. REVENUES +6.8%, EBITDA(1) +7.4%, NET INCOME +6.1%

Ads